Literature DB >> 32602890

Response to Lehrer and Rheinstein.

Stacey A Fedewa1, Jiemin Ma1, Ahmedin Jemal1.   

Abstract

Year:  2020        PMID： 32602890      PMCID： PMC7566380          DOI： 10.1093/jnci/djaa093

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Re: Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  J Natl Cancer Inst       Date:  2020-10-01       Impact factor: 13.506

2.  Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  David C Grossman; Susan J Curry; Douglas K Owens; Kirsten Bibbins-Domingo; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; Mark Ebell; John W Epling; Alex R Kemper; Alex H Krist; Martha Kubik; C Seth Landefeld; Carol M Mangione; Michael Silverstein; Melissa A Simon; Albert L Siu; Chien-Wen Tseng
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272

3.  Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.

Authors:  Ahmedin Jemal; MaryBeth B Culp; Jiemin Ma; Farhad Islami; Stacey A Fedewa
Journal:  J Natl Cancer Inst       Date:  2021-01-04       Impact factor: 13.506

4.  Annual report to the nation on the status of cancer, part I: National cancer statistics.

Authors:  S Jane Henley; Elizabeth M Ward; Susan Scott; Jiemin Ma; Robert N Anderson; Albert U Firth; Cheryll C Thomas; Farhad Islami; Hannah K Weir; Denise Riedel Lewis; Recinda L Sherman; Manxia Wu; Vicki B Benard; Lisa C Richardson; Ahmedin Jemal; Kathleen Cronin; Betsy A Kohler
Journal:  Cancer       Date:  2020-03-12       Impact factor: 6.921

5.  Cancer incidence, survival and mortality: explaining the concepts.

Authors:  Libby Ellis; Laura M Woods; Jacques Estève; Sandra Eloranta; Michel P Coleman; Bernard Rachet
Journal:  Int J Cancer       Date:  2014-06-19       Impact factor: 7.396
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.